B

Britannia Life Sciences Inc
F:L020

Watchlist Manager
Britannia Life Sciences Inc
F:L020
Watchlist
Price: 0.0415 EUR 1.22% Market Closed
Market Cap: 16.9m EUR

Operating Margin
Britannia Life Sciences Inc

0.9%
Current
-45%
Average
6.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0.9%
=
Operating Profit
35k
/
Revenue
3.9m

Operating Margin Across Competitors

No Stocks Found

Britannia Life Sciences Inc
Glance View

Market Cap
16.9m EUR
Industry
N/A

Britannia Life Sciences, Inc. is a global product development platform. The company is headquartered in Toronto, Ontario. The company went IPO on 2017-12-01. The firm's platform offers an integrated suite of services to assist companies along their product development journey. The firm provides product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally. The company is also engaged in the development and regulatory approval of topical and edible cannabis products, including preparation and support for food authorizations. The company serves consumer packaged goods (CPG), cosmetics, household goods and nutraceutical industries, blue-chip, food and beverage, nutraceutical sectors, toiletries, small and medium enterprise (SME) clients.

L020 Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0.9%
=
Operating Profit
35k
/
Revenue
3.9m
What is the Operating Margin of Britannia Life Sciences Inc?

Based on Britannia Life Sciences Inc's most recent financial statements, the company has Operating Margin of 0.9%.

Back to Top